|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 655 K Street NW, Suite 100 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20001-2399 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 4493-12
|
||||||||
|
6. House ID# 312430000
|
TYPE OF REPORT | 8. Year | 2019 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Matthew Shick |
Date | 4/22/2019 3:49:43 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Issue: Oppose draft legislation to restrict research with nonhuman primates.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Presidents Budget, FY 2020
Draft FY 2020 Labor-HHS-Education Appropriations Bills
Issues: Support funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), Hospital Preparedness Program, and biodefense, Ebola and public health preparedness programs. Oppose limitations on facilities and administrative reimbursement and on salary support. Maintain NIH salary cap at Executive Level II. Oppose reorganization of NIH and AHRQ without stakeholder input and deliberation. Oppose restrictions on fetal tissue research. Support funding for Health Resources and Services Administration (HRSA) workforce programs. Support funding for CDC Racial and Ethnic Approaches to Community Health program (REACH), Prevention Research Centers, and for research on gun violence. Support funding for Department of Education and federal student aid. Support funding to combat opioid epidemic and for new curricular materials. Support increased funding allocations for Labor-HHS-Education Subcommittee.
Draft legislation to increase discretionary spending caps
Issue: Increase discretionary spending caps and non-defense discretionary spending for fiscal year 2020 and 2021.
Presidents Budget, FY 2020
Draft FY 2020 Military Construction, Veterans Affairs, and Related Agencies Appropriations bills
Issue: Support funding for Veterans Affairs medical research, research infrastructure, and community care. Oppose restrictions on use of canines in VA medical research. Research IT.
P.L. 116-6, Consolidated Appropriations Act 2019, Divisions B, C, and E
H.R.21, Consolidated Appropriations Act
H.R.648, 2nd Consolidated Appropriations Act, 2019
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2019 (S. 3072 / H.R 5952 in the 115th Congress)
Issue: Support funding for the National Science Foundation (NSF), urge congress and president to resolve shutdown and re-open federal science and health agencies and programs. (e.g. NSF, FDA, IHS)
Issues: Oppose presidents budget proposal to eliminate and consolidate graduate medical education (GME) funding, and proposal to reduce payments to hospital outpatient departments (HOPDs).
Issue: Oppose presidents budget proposal to eliminate ACA Medicaid expansion and implement caps and/or block grants model, and to expand the Medicaid DSH cuts.
Issue: Oppose presidents budget proposal to reduce scope of the 340B Drug Pricing Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Christa |
Wagner |
PhD |
|
|
Allyson |
Perleoni |
|
|
|
Brett |
Roude |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Issue: Educate Congress on perspectives from the higher education community regarding technology transfer and the importance of the Bayh-Dole Act to the US patent system.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Draft, Higher Education Act reauthorization bills
Presidents Budget Request, FY 2020
Department of Education Higher Education Act reauthorization proposal
Issues: Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSLF) and elimination of GradPLUS loans.
Issue: Support a change to the Department of Education Financial Aid Handbook redefining the standard term for medical student loan disbursements.
Issue: Support initiatives to address and eliminate sexual harassment higher education.
Issue: Support single accreditation system for graduate medical education
Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice.
H.R.103, Foreign Medical School Accountability Fairness Act of 2019
Issue: Support transparency for all international medical schools.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Medicare Payment Advisory Commission (MedPAC), Education - Dept of, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Allyson |
Perleoni |
|
|
|
Karen |
Fisher |
JD |
|
|
Leonard |
Marquez |
|
|
|
Brett |
Roude |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.
Issue: Support the reauthorization of Health Resources and Services Administrations Title VII health professions workforce programs.
S. 192, Community and Public Health Programs Extension Act
S. 106, Community Health Investment, Modernization, and Excellence Act of 2019
S. 692, Community Health Center and Primary Care Workforce Expansion Act of 2019
Issue: Support the reauthorization of the National Health Service Corps, Community Health Centers, and Teaching Health Centers mandatory appropriation fund.
Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity.
Issue: Educate Congress and the administration about academic medicines response to the opioid epidemic. Support funding for training on substance use disorders, pain management, and safe prescribing practices.
Issue: Support reauthorization of the Patient Centered Outcomes Research Institute (PCORI) and the Patient Centered Outcomes Research Trust Fund
Issue: Oppose restrictions on fetal tissue research.
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (H.R. 7328/ H.R. 6378/S.2852/H.R. 4776 of the 115th congress)
Issue: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels.
Issue: Support continuation of high-quality affordable health insurance through preservation of current levels of health care coverage. Support programs and funds for safety-net providers.
Issue: Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including instituting a moratorium, increasing reporting requirements on covered entities, and imposing user fees
Draft, Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018
Draft, Diagnostic Accuracy and Innovation Act (DAIA)
Issue: Oppose burdensome regulation of Laboratory Developed Tests
Issue: Educate Congress on surprise medical bills and price transparency. Support general principles for surprise medical bills draft legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Drug Enforcement Administration (DEA), Office of Natl Drug Control Policy (NDCP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Allyson |
Perleoni |
JD |
|
|
Christa |
Wagner |
PhD |
|
|
Brett |
Roude |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 6, The American Dream and Promise Act of 2019
S. 874, The Dream Act of 2019
Issue: Support policies allowing undocumented students to attend U.S. medical schools and graduate medical education. Oppose rescission of Deferred Action for Childhood Arrivals (DACA) executive action without permanent replacement. Support Dreamer eligibility for federal student loans.
S. 948, Conrad State 30 and Physician Access Reauthorization Act
Issue: Support reauthorization and expansion of the Conrad 30 program, and improvements to physician immigration
Issue: Support policies to ensure timely and predictable processing for immigration of academic medicine community
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), White House Office, Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Brett |
Roude |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
P.L. 114-255, 21st Century Cures Act, Division A
Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators.
17. House(s) of Congress and Federal agencies Check if None
Office of Management & Budget (OMB), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Len |
Marquez |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issue: Support a delay in the implementation of the Medicaid disproportionate share hospital (DSH) cuts
Issue: ACA Medicaid expansion. Maintain commitment to match State spending on medical care for Medicaid beneficiaries without limits, caps, or block grants. Maintain and enforce network adequacy requirements and mandate sufficient payments to providers.
S. 585, States Achieve Medicaid Expansion (SAME) Act of 2019
Issue: Support legislation to allow states that expanded Medicaid after 2014 to receive the same full federal matching funds as states that previously expanded Medicaid under the Affordable Care Act
H.R. 1226, S. 317, Advancing Care for Exceptional (ACE) Kids Act of 2019
Issue: Support legislation to improve health care for children with complex medical conditions on Medicaid
H.R. 1763/ S. 348, Resident Shortage Physician Reduction Act of 2019
Issue: Support additional funding of graduate medical education
Draft Opioid Workforce Act
Issue: Support additional funding for graduate medical education for addiction medicine, addiction psychiatry, and pain management residency programs
S. 289, Rural Physician Workforce Production Act of 2019
Issue: Oppose legislation redesigning Medicare GME payment formulas
Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments
Issue: Oppose reduction of Medicare GME/IME payments
Issue: Oppose reduction in Medicare hospital outpatient department reimbursement.
Issue: Oppose Medicare hospital cuts
H.R.1358 - Advancing Medical Resident Training in Community Hospitals Act of 2019
Issue: Support Medicare Graduate Medical Education (GME) per resident amount and cap-setting technical corrections and administrative relief.
Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.
Issue: Oppose overly burdensome discussion draft Medicaid GME transparency legislation.
Issue: Educate Congress on role of academic medicine as it relates to price transparency initiatives
Issue: Support aligning 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA) for the purposes of treatment, payment, and healthcare operations.
Issue: Modify CMS Hospital Compare Star Ratings to allow stakeholders time to work together to address concerns with methodology. Support inclusion of sociodemographic status as part of quality programs
Issue: Support technical correction to increase access to physician services in rural communities by allowing teaching hospitals to count resident time spent in critical access hospitals for purposes of Medicare GME payments.
Issue: Oppose Health and Human Service Departments proposed rule on prescription drug rebates
Issue: Requested CMS solicit stakeholder feedback on the MS-DRG reassignment of percutaneous Extracorporeal Membrane Oxygenation (ECMO) in the upcoming IPPS FY 2020.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Len |
Marquez |
|
|
|
Tannaz |
Rasouli |
|
|
|
Matthew |
Shick |
J.D. |
|
|
Jason |
Kleinman |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Allyson |
Perleoni |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Issue: Support reducing administrative and regulatory burden on scientists and research institutions.
Issue: Support efforts to promote research integrity, address potential for foreign influence in science, and address harassment in science.
Issue: Support the use of a competitive peer review process for federal research grants and programs
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Health & Human Services - Dept of (HHS), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Karen |
Fisher |
J.D. |
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, and education partnerships.
Issue: Oppose eliminating authority for academic affiliates to administer NIH grants in support of VA investigators.
P.L. No: 115-182, VA Maintaining Internal Systems and Strengthening Integrated Outside Networks Act of 2018 (MISSION Act) Issue: Preserve direct sole-source contracting with academic affiliates to improve Veterans access to specialty care at academic medical centers. Support VA physician recruitment through scholarship, loan repayment, pilot programs, and immigration programs.
Issue: Support continuation of local flexibility and consideration of VAs statutory education and research missions in VA medical center referral determinations and procedures.
Issue: Support increased VA GME funding and Medicare GME funding for VA affiliates.
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
|
Christa |
Wagner |
PhD |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Issue: Educate Congress on the community benefit of not-for-profit hospitals and the importance of preserving their tax exempt status.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Shick |
J.D. |
|
|
Karen |
Fisher |
J.D. |
|
|
Tannaz |
Rasouli |
|
|
|
Len |
Marquez |
|
|
|
Allyson |
Perleoni |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
H.R. 965/S.340, The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019
H.R. 985, The Fair Access for Safe and Timely (FAST) Generics Act of 2019
H.R. 1520, The Purple Book Continuity Act of 2019
H.R. 1503, The Orange Book Transparency Act of 2019
Issue: Support policies to reduce prescription drug prices
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tannaz |
Rasouli |
|
|
|
Christa |
Wagner |
|
|
|
len |
Marquez |
|
|
|
jason |
kleinman |
|
|
|
Allyson |
Perleoni |
|
|
|
Karen |
Fisher |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |